Abstract: This paper proposes input current ripple analysis of three phase inverter with de-link referenced output filter, known as three phase modified buck-boost inverter. The filter consists of an ...

The next wave of high-efficiency DC-DC converters will reshape power delivery in applications ranging from DC microgrids to ...

Avatar: The Way of Water is in theaters this week only and has already contributed significantly to its already massive worldwide collection. The film has amassed more than $2 billion at the worldwide ...

This charging stand for iPhone, Apple Watch, and AirPods doesn't just support cutting-edge induction charging standard Qi2.2. "This design solves one of the biggest consumer frustrations when using ...

Israel and Hamas have agreed on the first phase of a peace plan in a “historic and unprecedented” moment, President Donald Trump said Wednesday. “This means that ALL of the Hostages will be released ...

Mumbai Metro Phase 3 Inauguration | Inside Mumbai Metro Line 3 Final Phase, PM Modi To Inaugurate Mumbai Metro Line 3 (Aqua Line) is scheduled to fully open on Oct. 8. It is the city’s first ...

Abstract: Split source inverters (SSIs) have gained attention as potential alternatives to conventional two-stage systems in applications that require integrating a dc source into an inverter ...

The US government agreed to acquire a stake in Lithium Americas Corp., giving a boost to the Canadian company as it develops its Thacker Pass lithium project in Nevada. The US will take a 5% equity ...

The converter regulates the variable output of a single-cell lithium-ion/polymer battery to a stable 3.3V output at up to 1.2A current. This project presents one of the easiest, compact, and efficient ...

CHICAGO, Sept 30 (Reuters) - U.S. President Donald Trump signed an executive order on Tuesday to bolster the use of artificial intelligence and provide an additional $50 million in research grants ...

MoonLake Immunotherapeutics’ stock has taken a pummeling after the biotech blamed an unexpectedly high placebo response rate for its much-hyped inflammatory disease prospect missing the key goal of ...